Cartherics, a biotech company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, has announced the granting of a patent for ‘Method for Providing Immune...

ITF Therapeutics, the U.S. affiliate of Italfarmaco, has announced publication of positive long-term safety and efficacy data for givinostat as a treatment for Duchenne muscular dystrophy (DMD) from the company’s open-label extensions of its...